Investment Rating - The report maintains a "Buy" rating for the company [7] Core Views - The company demonstrated strong revenue growth with total revenue of 38.15 billion RMB in 2H25, reflecting a year-on-year increase of 28.0%, surpassing the consensus estimate of 22.2% [1] - Non-IFRS net profit for 2H25 reached 2.96 billion RMB, up 37.9% year-on-year, with a non-IFRS net profit margin of 7.8%, an increase of 0.6 percentage points [1] - The company is expected to achieve a compound annual growth rate (CAGR) of 19.5% in revenue from 2025 to 2027, supported by enhanced operational capabilities in the pharmaceutical category [1][5] Revenue and Profitability - In 2H25, sales of pharmaceutical and health products amounted to 31.55 billion RMB, a year-on-year increase of 26.8%, indicating a recovery in growth rate compared to 1H25 [2] - The platform, advertising, and other service revenues reached 6.60 billion RMB, growing by 33.8% year-on-year, driven by a robust increase in user traffic [2] - The company plans to expand its offline business, having opened over 300 self-operated pharmacies by the end of 2025, significantly exceeding its initial target [3] AI and Technology Integration - The company has developed a product matrix in the AI medical field, including various AI tools for patient management and evidence-based medicine [4] - The AI doctor "Daiwei" has completed millions of interactions with a satisfaction rate of 98% [4] Financial Forecasts and Valuation - The report adjusts the non-IFRS net profit forecasts for 2026 and 2027 to 6.62 billion RMB and 7.75 billion RMB, respectively, reflecting a decrease due to interest income impacts and investments in O2O and AI [5][11] - The target price is set at 65.20 HKD, based on a 28.0x target non-IFRS PE valuation for 2026, which is a premium compared to the average PE of comparable companies [5][14]

Core Insights - The 2025 China International Service Trade Fair (CIFTIS) opened in Beijing, showcasing JD Group's innovations across various sectors including retail, technology, logistics, health, and industry, under the theme "Digital-Real Synergy, Smart Global Sharing" [1] - JD Group's "Seven Fresh Kitchen" and AI Interview Agent were recognized as exemplary service cases at the fair, highlighting their innovative supply chain and recruitment efficiency improvements [1][4] - JD Group aims to leverage its digital capabilities to optimize supply chains, reduce costs across industries, and enhance collaboration with over 100 state-owned enterprises [1] JD Group's Local Business Initiatives - JD's local services, including JD Takeout, Seven Fresh Kitchen, and JD Home Services, made their debut at the fair, focusing on addressing traditional industry pain points and enhancing home service market capabilities [2] - The "100 Billion Thousand Products New Growth Plan" by JD Global Purchase aims to introduce 1,000 new overseas brands and achieve 10 billion yuan in sales growth over three years [2] Technological Innovations - JD Cloud served as the official technology service provider for the fair, showcasing the "JD Office" smart government collaboration platform, which supports over 500,000 personnel in efficient cross-departmental collaboration [3] - The JoyAI model was highlighted with applications such as AI Interview Agent, which has improved recruitment efficiency by 70% and served over 100,000 job seekers [4] Supply Chain and Logistics Developments - JD's industrial solutions focus on creating a digital supply chain to enhance resilience and reduce costs by trillions, showcasing their integrated supply chain logistics system with over 30 new overseas warehouses [5][6] - JD's international supply chain capabilities were presented, emphasizing their infrastructure in over 50 locations across nine countries, aiming to become a preferred brand for Chinese enterprises going global [6] Health Services Innovations - JD Health demonstrated a closed-loop service model integrating medical consultations, testing, diagnosis, and medication delivery, enhancing online and offline healthcare service collaboration [5] - The introduction of AI medical products like "AI Jingyi" and "Kangkang" aims to provide comprehensive health management solutions across various scenarios [6] Vision and Future Goals - JD Group aspires to be the "most trusted global enterprise," leveraging its supply chain advantages to create value for global customers and partners, while promoting Chinese business civilization [6]